Open AccessImaging of dedifferentiated papillary thyroid carcinoma with left ventricular metastasis: A rare presentation of papillary thyroid metastatic disease
Author(s) -
Hooman Yarmohammadi,
Vania Tacher,
Peter Faulhaber,
Robert C. Gilkeson,
Recai Aktay,
Abdollah Kamouh,
Chen H Chow
Publication year - 2013
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.119307
Subject(s) - medicine , thyroid carcinoma , metastasis , magnetic resonance imaging , papillary thyroid cancer , thyroid cancer , thyroid , radiology , positron emission tomography , pathology , nuclear medicine , cancer
Cardiac metastasis in thyroid cancer is extremely rare. Iodine-131-d whole-body scan has been used widely to detect thyroid metastasis. However, in dedifferentiated cases, iodine scan has low diagnostic value particularly for diagnosing cardiac metastasis. In the absence of (131)I uptake, (18)F-fluoro-2-deoxyglucose positron emission tomography ((18)F-FDG PET) can be used as an alternative and has a high sensitivity for thyroid metastasis, but still low sensitivity for cardiac metastasis. Therefore, meticulous attention to the pattern of uptake and comparison with patients' previous studies is critical. Additionally, cardiac magnetic resonance imaging (MRI) can provide additional and critical information.